Lotus Pharm Co Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LOTUS PHARM CO LTD, and what generic and branded alternatives to LOTUS PHARM CO LTD drugs are available?
LOTUS PHARM CO LTD has seven approved drugs.
There are two tentative approvals on LOTUS PHARM CO LTD drugs.
Summary for Lotus Pharm Co Ltd
| US Patents: | 0 |
| Tradenames: | 6 |
| Ingredients: | 6 |
| NDAs: | 7 |
Drugs and US Patents for Lotus Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090906-001 | Nov 5, 2010 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090906-002 | Oct 31, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Lotus Pharm Co Ltd | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 210480-002 | Aug 31, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090906-004 | Oct 31, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Lotus Pharm Co Ltd | METHOTREXATE SODIUM | methotrexate sodium | TABLET;ORAL | 209787-001 | Apr 23, 2021 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Lotus Pharm Co Ltd | LENALIDOMIDE | lenalidomide | CAPSULE;ORAL | 210480-003 | Aug 31, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
